GABAAR π has been shown to stimulate breast cancer cell invasion through the ERK1/2 pathway (Sizemore et al., 2014) and it also interacts with EGFR and sustains EGFR expression in TNBC (Li et al., 2021). Here, EGFR is linked to breast carcinoma.